Dark
Light
System
Security
Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.. Institutional holdings reported to the SEC.

Institutional Holders (2016Q3)
Portfolio Summary: 3 Institutional holders with a total value of $2,090,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 DOHENY ASSET MANAGEMENT /CA 130,950 1,582,000 75.69%
2 J.P. Morgan Private Wealth Advisors LLC 42,000 507,000 24.26%
3 Plante Moran Financial Advisors, LLC 90 1,000 0.05%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.